Facial Injectable Market Segmented By Dermal Fillers and Botulinum toxin in Aesthetic Restoration, Dentistry and Reconstructive Surgery
Industry: Healthcare
Published Date: November-2018
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 183
Report ID: PMRREP14350
1. Executive Summary – Facial Injectable Market
1.1. Market Summary
1.2. Analysis Summary
1.3. Megatrends in Metagenomics Market
1.4. Opportunity Assessment
1.5. Wheel of FortuneTM Opportunity Analysis
1.6. Fact.MR View Point
2. Market Overview
2.1. Market Introduction
2.2. Market Definition
2.3. Scope of the Report
3. Market Dynamics
3.1. Macro - Economic Factors Influencing Demand
3.2. Key Growth Drivers and Impact Analysis
3.3. Industry Challenges and Restraints
3.4. Forecast Factors and Relevance of Impact
3.5. Supply Chain Analysis
3.5.1. List of Key Manufacturers
3.5.2. Key Distributors
3.6. Regulatory Guidelines
4. Facial Injectable Market – Key Inclusions
4.1. Regulatory Scenario
4.2. Pricing Analysis
4.3. Factors Influencing Pricing
5. Global Facial Injectable Market Analysis and Forecast
5.1. Facial Injectable Market Outlook
5.1.1. Market Value Forecast and Analysis
5.1.2. Regional Demand Assessment
5.1.2.1. Market Value Share by Region
5.2. Facial Injectable Market Analysis by Product Type
5.2.1. Botulinum Toxin
5.2.1.1. Toxin A
5.2.1.2. Toxin B
5.2.2. Dermal Fillers
5.2.2.1. Hyaluronic Acid
5.2.2.2. Poly-L-Lactic Acid
5.2.2.3. Calcium Hydroxyapatite
5.2.2.4. Poly Methyl methacrylate
5.3. Facial Injectable Market Analysis by Applications
5.3.1. Aesthetic Restoration
5.3.2. Dentistry
5.3.3. Reconstructive Surgery
5.4. Facial Injectable Market Analysis by End User
5.4.1. Hospital
5.4.2. Specialty Clinics
5.4.3. Spa & Beauty Clinic
6. North America Facial Injectable Market Analysis
6.1. Introduction
6.1.1. North America Business Outlook
6.1.2. North America Facial Injectable Market Outlook
6.2. North America Facial Injectable Market Outlook
6.2.1. Market Value (US$ Mn) and Analysis
6.2.2. Country Wise Demand Assessment
6.2.2.1. US Market Value Share
6.2.2.2. Canada Market Value Share
6.3. North America Facial Injectable Market Analysis by Product Type
6.3.1. Value (US$ Mn) and Forecast by Product Type
6.3.2. Y-o-Y Growth Comparison by Product Type
6.4. North America Facial Injectable Market Analysis by Applications
6.4.1. Value (US$ Mn) and Forecast by Applications
6.4.2. Y-o-Y Growth Comparison by Applications
6.5. North America Facial Injectable Market Analysis by End User
6.5.1. Value (US$ Mn) and Forecast by End User
6.5.2. Y-o-Y Growth Comparison by End User
6.6. Market Attractiveness Analysis
6.7. List of Key Market Participants By Country
6.8. Heat Map Analysis
6.9. Impact Assessment of Market Forces
7. Latin America Facial Injectable Market Analysis
7.1. Introduction
7.1.1. Latin America Business Outlook
7.1.2. Latin America metagenomics Market Outlook
7.2. Latin America Facial Injectable Market Outlook
7.2.1. Market Value (US$ Mn) and Analysis
7.2.2. Country Wise Demand Assessment
7.2.2.1. Brazil Market Value Share
7.2.2.2. Mexico Market Value Share
7.2.2.3. Rest of LATAM Market Value Share
7.3. Latin America Injectable Market Analysis by Product Type
7.3.1. Value (US$ Mn) and Forecast by Product Type
7.3.2. Y-o-Y Growth Comparison by Product Type
7.4. Latin America Facial Injectable Market Analysis by Applications
7.4.1. Value (US$ Mn) and Forecast by Modality
7.4.2. Y-o-Y Growth Comparison by Modality
7.5. Latin America Facial Injectable Market Analysis by End User
7.5.1. Value (US$ Mn) and Forecast by End User
7.5.2. Y-o-Y Growth Comparison by End User
7.6. Market Attractiveness Analysis
7.7. List of Key Market Participants By Country
7.8. Heat Map Analysis
7.9. Impact Assessment of Market Forces
8. Europe Facial Injectable Market Analysis
8.1. Introduction
8.1.1. Europe Business Outlook
8.1.2. Europe Metagenomics Market Outlook
8.2. Europe Facial Injectable Market Outlook
8.2.1. Market Value (US$ Mn) and Analysis
8.2.2. Country Wise Demand Assessment
8.2.2.1. Germany Market Value Share
8.2.2.2. UK Market Value Share
8.2.2.3. France Market Value Share
8.2.2.4. Italy Market Value Share
8.2.2.5. Spain Market Value Share
8.2.2.6. Russia Market Value Share
8.2.2.7. Poland Market Value Share
8.2.2.8. Rest of Europe Market Value Share
8.3. Europe Metagenomics Market Analysis by Product Type
8.3.1. Value (US$ Mn) and Forecast by Product Type
8.3.2. Y-o-Y Growth Comparison by Product Type
8.4. Europe Metagenomics Market Analysis by Applications
8.4.1. Value (US$ Mn) and Forecast by Applications
8.4.2. Y-o-Y Growth Comparison by Applications
8.5. Europe Metagenomics Market Analysis by End User
8.5.1. Value (US$ Mn) and Forecast by End User
8.5.2. Y-o-Y Growth Comparison by End User
8.6. Market Attractiveness Analysis
8.7. List of Key Market Participants By Country
8.8. Heat Map Analysis
8.9. Impact Assessment of Market Forces
9. Asia Pacific Facial Injectable Market Analysis and Forecast
9.1. Introduction
9.1.1. Asia Pacific Business Outlook
9.1.2. Asia Pacific Facial Injectable Market Outlook
9.2. Asia Pacific Facial Injectable Market Outlook
9.2.1. Market Value (US$ Mn) and Analysis
9.2.2. Country Wise Demand Assessment
9.2.2.1. China Market Value Share
9.2.2.2. India Market Value Share
9.2.2.3. Australia Market Value Share
9.2.2.4. ASEAN Market Value Share
9.2.2.5. Japan Market Value Share
9.2.2.6. Rest of APAC Market Value Share
9.3. Asia Pacific Facial Injectable Market Analysis by Product Type
9.3.1. Value (US$ Mn) and Forecast by Product Type
9.3.2. Y-o-Y Growth Comparison by Product Type
9.4. Asia Pacific Facial Injectable Market Analysis by Applications
9.4.1. Value (US$ Mn) and Forecast by Applications
9.4.2. Y-o-Y Growth Comparison by Applications
9.5. Asia Pacific Facial Injectable Market Analysis by End User
9.5.1. Value (US$ Mn) and Forecast by End User
9.5.2. Y-o-Y Growth Comparison by End User
9.6. Market Attractiveness Analysis
9.7. List of Key Market Participants By Country
9.8. Heat Map Analysis
9.9. Impact Assessment of Market Forces
10. MEA Facial Injectable Market Analysis and Forecast
10.1. Introduction
10.1.1. MEA Business Outlook
10.1.2. MEA Facial Injectable Market Outlook
10.2. MEA Facial Injectable Market Outlook
10.2.1. Market Value (US$ Mn) and Analysis
10.2.2. Country Wise Demand Assessment
10.2.2.1. GCC Countries Market Value Share
10.2.2.2. South Africa Market Value Share
10.2.2.3. Rest of MEA Market Value Share
10.3. MEA Facial Injectable Market Analysis by Product Type
10.3.1. Value (US$ Mn) and Forecast by Product Type
10.3.2. Y-o-Y Growth Comparison by Product Type
10.4. MEA Facial Injectable Market Analysis by Applications
10.4.1. Value (US$ Mn) and Forecast by Applications
10.4.2. Y-o-Y Growth Comparison by Applications
10.5. MEA Facial Injectable Market Analysis by End User
10.5.1. Value (US$ Mn) and Forecast by End User
10.5.2. Y-o-Y Growth Comparison by End User
10.6. Market Attractiveness Analysis
10.7. List of Key Market Participants By Country
10.8. Heat Map Analysis
10.9. Impact Assessment of Market Forces
11. Competitive Assessment
11.1. Global Facial Injectable Market Competition - a Dashboard View
11.2. Global Facial Injectable Market Structure
11.3. Global Facial Injectable Market Company Share Analysis
12. Company Profiles
12.1. Nestle Skin Health
12.1.1. Manufacturing facilities Across Globe, 2017
12.1.2. Company Revenue Share
12.1.3. Key Financials*
12.1.4. SWOT Analysis
12.2. Sinclair Pharma
12.2.1. Manufacturing facilities Across Globe, 2017
12.2.2. Company Revenue Share
12.2.3. Key Financials*
12.2.4. SWOT Analysis
12.3. Zimmer Biomet
12.3.1. Manufacturing facilities Across Globe, 2017
12.3.2. Company Revenue Share
12.3.3. Key Financials*
12.3.4. SWOT Analysis
12.4. Allergan
12.4.1. Manufacturing facilities Across Globe, 2017
12.4.2. Company Revenue Share
12.4.3. Key Financials*
12.4.4. SWOT Analysis
12.5. Anika Therapeutics, Inc.
12.5.1. Manufacturing facilities Across Globe, 2017
12.5.2. Company Revenue Share
12.5.3. Key Financials*
12.5.4. SWOT Analysis
12.6. Merz Pharma
12.6.1. Manufacturing facilities Across Globe, 2017
12.6.2. Company Revenue Share
12.6.3. Key Financials*
12.6.4. SWOT Analysis
12.7. Ipsen Pharma
12.7.1. Manufacturing facilities Across Globe, 2017
12.7.2. Company Revenue Share
12.7.3. Key Financials*
12.7.4. SWOT Analysis
12.8. Teoxane Laboratories
12.8.1. Manufacturing facilities Across Globe, 2017
12.8.2. Company Revenue Share
12.8.3. Key Financials*
12.8.4. SWOT Analysis
12.9. Prollenium Medical Technologies
12.9.1. Manufacturing facilities Across Globe, 2017
12.9.2. Company Revenue Share
12.9.3. Key Financials*
12.9.4. SWOT Analysis
12.10. Suneva Medical, Inc.
12.10.1. Manufacturing facilities Across Globe, 2017
12.10.2. Company Revenue Share
12.10.3. Key Financials*
12.10.4. SWOT Analysis
13. Assumptions and Acronyms Used
14. Research Methodology
Table 01: Global Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Country (2013-2028)
Table 02: Global Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Product Type (2013-2028)
Table 03: Global Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Application (2013-2028)
Table 04: Global Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2013-2028)
Table 05: North America Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Country (2013-2028)
Table 06: North America Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Product Type (2013-2028)
Table 07: North America Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Application (2013-2028)
Table 08: North America Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2013-2028)
Table 09: Latin America Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Country (2013-2028)
Table 10: Latin America Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Product Type (2013-2028)
Table 11: Latin America Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Application (2013-2028)
Table 12: Latin America Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2013-2028)
Table 13: Europe Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Country (2013-2028)
Table 14: Europe Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Product Type (2013-2028)
Table 15: Europe Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Application (2013-2028)
Table 16: Europe Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2013-2028)
Table 17: Asia Pacific Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Country (2013-2028)
Table 18: Asia Pacific Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Product Type (2013-2028)
Table 19: Asia Pacific Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Application (2013-2028)
Table 20: Asia Pacific Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2013-2028)
Table 21: MEA Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Country (2013-2028)
Table 22: MEA Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Product Type (2013-2028)
Table 23: MEA Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Application (2013-2028)
Table 24: MEA Facial Injectable Market Value (US$ Mn) Analysis and Forecast, By Distribution Channel (2013-2028)
Figure 01: Facial Injectable Market Revenue Share by Product Type, 2018 & 2018
Figure 02: Facial Injectable Market Revenue Share by Application, 2018E & 2028F
Figure 03: Facial Injectable Market Revenue Share by end users, 2018E & 2028F
Figure 04: Facial Injectable Market Revenue Share by Region, 2018E & 2028F
Figure 05: Wheel of Fortune
Figure 06: Global Facial Injectable Historical Market Size, 2013 - 2017
Figure 07: Global Facial Injectable Market Size (US$ Mn) & Y-o-Y analysis, 2017 - 2028
Figure 08: North America Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 09: North America Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 10: Latin America Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 11: Latin America Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 12: Europe Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 13: Europe Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 14: Asia Pacific Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 15: Asia Pacific Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 16: MEA Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 17: MEA Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 18: Global Facial Injectable Historical Market Size (US$ Mn) By Botulinum toxin, 2013–2017
Figure 19: Global Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%) By Botulinum, 2017–2028
Figure 20: Global Facial Injectable Historical Market Size (US$ Mn) By Dermal Filler, 2013–2017
Figure 21: Global Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%) By Dermal Fillers, 2017–2028
Figure 22: Global Facial Injectable Market Attractiveness Analysis by Country, 2018–2028
Figure 23: Global Facial Injectable Market Attractiveness Analysis by Product Type, 2018–2028
Figure 24: Global Facial Injectable Market Attractiveness Analysis by Application, 2018–2028
Figure 25: Global Facial Injectable Market Attractiveness Analysis by End User, 2018–2028
Figure 26: North America Facial Injectable Historical Market Size, 2013 - 2017
Figure 27: North America Facial Injectable Market Size (US$ Mn) & Y-o-Y analysis, 2017 - 2028
Figure 28: U.S Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 29: U.S. Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 30: Canada Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 31: Canada Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 32: North America Facial Injectable Historical Market Size (US$ Mn) By Botulinum toxin, 2013–2017
Figure 33: North America Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%) By Botulinum, 2017–2028
Figure 34: North America Facial Injectable Historical Market Size (US$ Mn) By Dermal Filler, 2013–2017
Figure 35: North America Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%) By Dermal Fillers, 2017–2028
Figure 36: North America Facial Injectable Market Attractiveness Analysis by Country, 2018–2028
Figure 37: North America Facial Injectable Market Attractiveness Analysis by Product Type, 2018–2028
Figure 38: North America Facial Injectable Market Attractiveness Analysis by Application, 2018–2028
Figure 39: North America Facial Injectable Market Attractiveness Analysis by End User, 2018–2028
Figure 40: Latin America Facial Injectable Historical Market Size, 2013 - 2017
Figure 41: Latin America Facial Injectable Market Size (US$ Mn) & Y-o-Y analysis, 2017 - 2028
Figure 42: Brazil Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 43: Brazil Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 44: Mexico Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 45: Mexico Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 46: Rest of Latin America Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 47: Rest of Latin America Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 48: Latin America Facial Injectable Historical Market Size (US$ Mn) By Botulinum toxin, 2013–2017
Figure 49: Latin America Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%) By Botulinum, 2017–2028
Figure 50: Latin America Facial Injectable Historical Market Size (US$ Mn) By Dermal Filler, 2013–2017
Figure 51: Latin America Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%) By Dermal Fillers, 2017–2028
Figure 52: Latin America Facial Injectable Market Attractiveness Analysis by Country, 2018–2028
Figure 53: Latin America Facial Injectable Market Attractiveness Analysis by Product Type, 2018–2028
Figure 54: Latin America Facial Injectable Market Attractiveness Analysis by Application, 2018–2028
Figure 55: Latin America Facial Injectable Market Attractiveness Analysis by End User, 2018–2028
Figure 56: Europe Facial Injectable Historical Market Size, 2013 - 2017
Figure 57: Europe Facial Injectable Market Size (US$ Mn) & Y-o-Y analysis, 2017 - 2028
Figure 58: Germany Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 59: Germany Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 60: U.K Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 61: U.K Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 62: France Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 63: France Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 64: Italy Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 65: Italy Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 66: Spain Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 67: Spain Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 68: Russia Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 69: Russia Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 70: Poland Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 71: Poland Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 72: Rest of Europe Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 73: Rest of Europe Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 74: Europe Facial Injectable Historical Market Size (US$ Mn) By Botulinum toxin, 2013–2017
Figure 75: Europe Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%) By Botulinum, 2017–2028
Figure 76: Europe Facial Injectable Historical Market Size (US$ Mn) By Dermal Filler, 2013–2017
Figure 77: Europe Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%) By Dermal Fillers, 2017–2028
Figure 78: Europe Facial Injectable Market Attractiveness Analysis by Country, 2018–2028
Figure 79: Europe Facial Injectable Market Attractiveness Analysis by Product Type, 2018–2028
Figure 80: Europe Facial Injectable Market Attractiveness Analysis by Application, 2018–2028
Figure 81: Europe Facial Injectable Market Attractiveness Analysis by End User, 2018–2028
Figure 82: Asia Pacific Facial Injectable Historical Market Size, 2013 - 2017
Figure 83: Asia Pacific Facial Injectable Market Size (US$ Mn) & Y-o-Y analysis, 2017 - 2028
Figure 84: China Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 85: China Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 86: India Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 87: India Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 88: Australia Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 89: Australia Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 90: ASEAN Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 91: ASEAN Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 92: Japan Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 93: Japan Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 94: Rest of APAC Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 95: Rest of APAC Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 96: Asia Pacific Facial Injectable Historical Market Size (US$ Mn) By Botulinum toxin, 2013–2017
Figure 97: Asia Pacific Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%) By Botulinum, 2017–2028
Figure 98: Asia Pacific Facial Injectable Historical Market Size (US$ Mn) By Dermal Filler, 2013–2017
Figure 99: Asia Pacific Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%) By Dermal Fillers, 2017–2028
Figure 100: Asia Pacific Facial Injectable Market Attractiveness Analysis by Country, 2018–2028
Figure 101: Asia Pacific Facial Injectable Market Attractiveness Analysis by Product Type, 2018–2028
Figure 102: Asia Pacific Facial Injectable Market Attractiveness Analysis by Application, 2018–2028
Figure 103: Asia Pacific Facial Injectable Market Attractiveness Analysis by End User, 2018–2028
Figure 104: Asia Pacific Facial Injectable Historical Market Size, 2013 - 2017
Figure 105: Asia Pacific Facial Injectable Market Size (US$ Mn) & Y-o-Y analysis, 2017 - 2028
Figure 106: GCC Countries Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 107: GCC Countries Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 108: South Africa Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 109: South Africa Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 110: Rest of MEA Facial Injectable Historical Market Size (US$ Mn), 2013–2017
Figure 111: Rest of MEA Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028
Figure 112: MEA Facial Injectable Historical Market Size (US$ Mn) By Botulinum toxin, 2013–2017
Figure 113: MEA Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%) By Botulinum, 2017–2028
Figure 114: MEA Facial Injectable Historical Market Size (US$ Mn) By Dermal Filler, 2013–2017
Figure 115: MEA Facial Injectable Market Size (US$ Mn) & Y-o-Y Growth (%) By Dermal Fillers, 2017–2028
Figure 116: MEA Facial Injectable Market Attractiveness Analysis by Country, 2018–2028
Figure 117: MEA Facial Injectable Market Attractiveness Analysis by Product Type, 2018–2028
Figure 118: MEA Facial Injectable Market Attractiveness Analysis by Application, 2018–2028
Figure 119: MEA Facial Injectable Market Attractiveness Analysis by End User, 2018–2028